Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
11.96
+0.39 (3.37%)
At close: Aug 13, 2025, 4:00 PM
11.99
+0.03 (0.25%)
After-hours: Aug 13, 2025, 7:48 PM EDT
Roivant Sciences Market Cap
Roivant Sciences has a market cap or net worth of $8.16 billion as of August 13, 2025. Its market cap has increased by 2.25% in one year.
Market Cap
8.16B
Enterprise Value
3.38B
1-Year Change
2.25%
Ranking
Category
Stock Price
$11.96
Market Cap Chart
Since December 8, 2020, Roivant Sciences's market cap has increased from $533.38M to $8.16B, an increase of 1,430.43%. That is a compound annual growth rate of 79.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 7.90B | -8.30% |
| Dec 31, 2024 | 8.61B | -4.61% |
| Dec 29, 2023 | 9.03B | 55.76% |
| Dec 30, 2022 | 5.80B | -18.13% |
| Dec 31, 2021 | 7.08B | 1,257.32% |
| Dec 31, 2020 | 521.58M | -2.21% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 561.67B |
| Johnson & Johnson | 417.44B |
| AbbVie | 349.87B |
| Abbott Laboratories | 233.71B |
| AstraZeneca | 227.85B |
| UnitedHealth Group | 227.59B |
| Novartis AG | 225.61B |
| Novo Nordisk | 224.34B |